Carrier Frequency of Spinal Muscular Atrophy in a Large-scale Korean Population
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by progressive proximal muscle weakness and atrophy. Given the recent introduction of gene therapies, knowledge of the SMA carrier frequency in various populations has become important for developing screening programs for this disease. In total, 1,581 anonymous DNA samples from an umbilical cord blood bank were tested for SMN1 and SMN2 gene copies using a multiplex ligation-dependent probe amplification assay. Twenty-nine of the 1,581 newborns [1.83%; 95% confidence interval (CI), 1.25–2.66%] were SMA carriers with one copy of SMN1, and no homozygous SMN1 deletion was detected. The carrier frequency in this population was estimated to be 1,834 per 100,000 (95% CI, 1,254– 2,659) or 1 in 55 (95% CI, 1/79–1/38). Our data indicate that SMA carriers are not uncommon in the Korean population and may serve as a reference for designing a population screening program in Korea.
Abstract
Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by progressive proximal muscle weakness and atrophy. Given the recent introduction of gene therapies, knowledge of the SMA carrier frequency in various populations has become important for developing screening programs for this disease. In total, 1,581 anonymous DNA samples from an umbilical cord blood bank were tested for SMN1 and SMN2 gene copies using a multiplex ligation-dependent probe amplification assay. Twenty-nine of the 1,581 newborns [1.83%; 95% confidence interval (CI), 1.25–2.66%] were SMA carriers with one copy of SMN1, and no homozygous SMN1 deletion was detected. The carrier frequency in this population was estimated to be 1,834 per 100,000 (95% CI, 1,254– 2,659) or 1 in 55 (95% CI, 1/79–1/38). Our data indicate that SMA carriers are not uncommon in the Korean population and may serve as a reference for designing a population screening program in Korea.
참고문헌 (20)
- "Spinal Muscular Atrophy" (2000)[URL]
- Lunn MR, "Spinal muscular atrophy", Lancet, 371, pp.2120~2133 (2008)
- Finkel RS, "Nusinersen versus sham control in infantile-onset spinal muscular atrophy", N Engl J Med, 377, pp.1723~1732 (2017)
- Little SE, "The cost-effectiveness of prenatal screening for spinal muscular atrophy", Am J Obstet Gynecol, 202, pp.253.e1~253.e7 (2010)
- Zhang L, "Population genomic screening of all young adults in a health-care system : a cost-effectiveness analysis", Genet Med, 21, pp.1958~1968 (2019)
- 윤서영, "Determination of SMN1 and SMN2 Copy Numbers in a Korean Population using Multiplex Ligation-dependent Probe Amplification", Annals of Laboratory Medicine, 30(1), pp.93~96 (2010), 대한진단검사의학회
- 이태미, "Quantitative Analysis of SMN1 Gene and Estimation of SMN1 Deletion Carrier Frequency in Korean Population based on Real-Time PCR", Journal of Korean Medical Science, 19(6), pp.870~873 (2004), 대한의학회
- Luo M, "An Ashkenazi Jewish SMN1 haplotype specific to duplication alleles improves pan-ethnic carrier screening for spinal muscular atrophy", Genet Med, 16, pp.149~156 (2014)
- Verhaart IEC, "Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy–a literature review", Orphanet J Rare Dis, 12, pp.124~ (2017)
- Chan V, "Carrier incidence for spinal muscular atrophy in southern Chinese", J Neurol, 251, pp.1089~1093 (2004)
- Sheng-Yuan Z, "Molecular characterization of SMN copy number derived from carrier screening and from core families with SMA in a Chinese population", Eur J Hum Genet, 18, pp.978~984 (2010)
- Qu XX, "A pilot study on spinal muscular atrophy carrier screening in Shanghai region using real-time PCR", Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 30, pp.1~4 (2013)
- Gong B, "Carrier screening for spinal muscular atrophy in 4719 pregnant women in Shanghai region", Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 30, pp.670~672 (2013)
- Tan J, "Screening for spinal muscular atrophy mutation carriers among 4931 pregnant women from Liuzhou region of Guangxi", Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 35, pp.467~470 (2018)
- Huang CH, "Copy number analysis of survival motor neuron genes by multiplex ligation-dependent probe amplification", Genet Med, 9, pp.241~248 (2007)
- Chen TH, "Identification of bidirectional gene conversion between SMN1 and SMN2 by simultaneous analysis of SMN dosage and hybrid genes in a Chinese population", J Neurol Sci, 308, pp.83~87 (2011)
- Su YN, "Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study", PLoS One, 6, pp.e17067~ (2011)
- Wang KC, "Evaluation and characterization of a high-resolution melting analysis kit for rapid carrier-screening test of spinal muscular atrophy", J Neurogenet, 29, pp.113~116 (2015)
- Prior TW, "Carrier screening for spinal muscular atrophy", Genet Med, 10, pp.840~842 (2008)
- "Committee Opinion No. 691: Carrier Screening for Genetic Conditions", Obstetrics & Gynecology, 129(3), pp.e41~e55 (2017), Ovid Technologies (Wolters Kluwer Health)[DOI]